A new study analyzed how often people develop severe side effects after taking semaglutide — known by brand names Ozempic and ...

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...

Hims & Hers launched a pharmacy-made weight-loss drug last year, taking advantage of an FDA rule allowing it to temporarily ...

Researchers say semaglutide, the medication in Ozempic and Wegovy, may help reverse MASH, a progressive liver condition ...

The WHO announced its plan to support GLP-1 weight-loss drugs, like Wegovy and Zepbound, to address the global obesity ...

More than 2.5 billion adults worldwide are currently overweight or obese, according to estimates from the World Health ...

Semaglutide, the active ingredient in popular drugs Ozempic and Wegovy, isn’t without its risks. A recent study has found ...

Mukhopadhyay took Mounjaro, an antidiabetic medication also used for weight loss, and saw dramatic results—losing 15 percent ...

Sometimes, it makes sense to skip insurance and instead take advantage of a health savings account or flexible savings ...

Therefore, for sensitive weight and weight loss drug related questions, Swiss Re suggested fostering anonymity over a “human touch” may help applicants feel more comfortable and enhance ...

Although it has not been approved for NHS use solely as a weight-loss treatment, the rising demand for such drugs could lead to supply shortages. This risks depriving diabetes patients of ...

CMS has historically prohibited coverage of these drugs under Medicare Part D, a relic of a decades-old federal statute that excluded "agents when used for anorexia, weight loss, or weight gain ...